According to 10x Genomics 's latest financial reports the company's current revenue (TTM) is $0.61 B. In 2022 the company made a revenue of $0.51 B an increase over the years 2021 revenue that were of $0.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.61 B | 19.81% |
2022 | $0.51 B | 5.28% |
2021 | $0.49 B | 64.13% |
2020 | $0.29 B | 21.53% |
2019 | $0.24 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -99.96% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | -96.47% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 12.08% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | -17.68% | Jersey |